import{_ as t}from"./plugin-vue_export-helper-DlAUqK2U.js";import{o,c as n,b as e}from"./app-VmWJ2sMR.js";const a="/seminar/assets/image/speech.jpg",r={},i=e("p",null,"Immunotherapy for tumors has been touted as the hope for overcoming cancer, and whether it's the PD-1 immune checkpoint inhibitor therapies that have been approved for numerous cancers so far, or the over-the-counter cellular immunotherapy represented by CAR-T, or the many cancer vaccines that are in full swing of development, they are just the tip of the immunological iceberg. Researchers are digging into the iceberg to find out more about how to control the immune response and how these therapies can be used in the clinic to reap the benefits, giving us more and more hope for survival, and perhaps the hope of conquering cancer. Expect more breakthroughs in immunotherapy and more miracles for cancer patients.",-1),s=e("p",null,"The 6th International Conference on Cancer Immunotherapy will be held June 1-3, 2024 in Shanghai, China. The conference covers topics including tumor microenvironment, cytokine therapy, immunotherapy for solid tumors, preclinical research and translational medicine. Welcome to the 6th International Conference on Cancer Immunotherapy.",-1),c=e("figure",null,[e("img",{src:a,alt:"Professor Germain is giving a lecture",tabindex:"0",loading:"lazy"}),e("figcaption",null,"Professor Germain is giving a lecture")],-1),m=e("p",null,"Professor Germain of the National Institutes of Health, member of the American Academy of Medicine; Professor Andreas Radbruch of the Rheumatism Research Center Berlin, member of the German Academy of Sciences, and 15 other top international immunologists, and 19 domestic scholars representing the top level of China's immunology research, including Academician Cao Xuetao, President of the Chinese Academy of Medical Sciences and Secretary General of the Chinese Society of Immunology, and Academician Han Jiahuai of the School of Life Sciences at Xiamen University, respectively, discussed the immunity of tumors and Tumor immunotherapy, infection immunity, autoimmune diseases, differentiation and development of immune cells, molecular mechanism of T/B cell immune response, recognition and regulation of natural immune response, clinical immunology technology and its application and other immunology related areas of research hot spots and development trend of the conference made a wonderful report. There were more than 1800 registered delegates, 971 abstracts and 50 exhibitors.",-1),h=e("p",null,"Welcome all the experts and scholars to come to Shanghai for an academic event, and we also hope that you will have a good time in Shanghai!",-1),p=[i,s,c,m,h];function l(u,d){return o(),n("div",null,p)}const y=t(r,[["render",l],["__file","2.html.vue"]]),b=JSON.parse(`{"path":"/news/2024/2.html","title":"Welcome to ICCI-2024","lang":"en-US","frontmatter":{"cover":"/assets/image/groupphoto.jpg","title":"Welcome to ICCI-2024","date":"2024-04-21T00:00:00.000Z","category":["News"],"tag":["2024"],"star":true,"sticky":true,"description":"Immunotherapy for tumors has been touted as the hope for overcoming cancer, and whether it's the PD-1 immune checkpoint inhibitor therapies that have been approved for numerous ...","head":[["meta",{"property":"og:url","content":"https://zhang-guodong.github.io/seminar/seminar/news/2024/2.html"}],["meta",{"property":"og:site_name","content":"ICCI"}],["meta",{"property":"og:title","content":"Welcome to ICCI-2024"}],["meta",{"property":"og:description","content":"Immunotherapy for tumors has been touted as the hope for overcoming cancer, and whether it's the PD-1 immune checkpoint inhibitor therapies that have been approved for numerous ..."}],["meta",{"property":"og:type","content":"article"}],["meta",{"property":"og:image","content":"https://zhang-guodong.github.io/seminar/seminar/assets/image/groupphoto.jpg"}],["meta",{"property":"og:locale","content":"en-US"}],["meta",{"property":"og:updated_time","content":"2024-04-22T17:15:43.000Z"}],["meta",{"name":"twitter:card","content":"summary_large_image"}],["meta",{"name":"twitter:image:src","content":"https://zhang-guodong.github.io/seminar/seminar/assets/image/groupphoto.jpg"}],["meta",{"name":"twitter:image:alt","content":"Welcome to ICCI-2024"}],["meta",{"property":"article:author","content":"ICCI"}],["meta",{"property":"article:tag","content":"2024"}],["meta",{"property":"article:published_time","content":"2024-04-21T00:00:00.000Z"}],["meta",{"property":"article:modified_time","content":"2024-04-22T17:15:43.000Z"}],["script",{"type":"application/ld+json"},"{\\"@context\\":\\"https://schema.org\\",\\"@type\\":\\"Article\\",\\"headline\\":\\"Welcome to ICCI-2024\\",\\"image\\":[\\"https://zhang-guodong.github.io/seminar/seminar/assets/image/speech.jpg\\"],\\"datePublished\\":\\"2024-04-21T00:00:00.000Z\\",\\"dateModified\\":\\"2024-04-22T17:15:43.000Z\\",\\"author\\":[{\\"@type\\":\\"Person\\",\\"name\\":\\"ICCI\\",\\"url\\":\\"https://github.com/zhang-guodong\\"}]}"]]},"headers":[],"git":{"createdTime":1713715482000,"updatedTime":1713806143000,"contributors":[{"name":"Guodong Zhang","email":"gd.zhang@live.com","commits":2}]},"readingTime":{"minutes":1.24,"words":372},"filePathRelative":"news/2024/2.md","localizedDate":"April 21, 2024","excerpt":"<p>Immunotherapy for tumors has been touted as the hope for overcoming cancer, and whether it's the PD-1 immune checkpoint inhibitor therapies that have been approved for numerous cancers so far, or the over-the-counter cellular immunotherapy represented by CAR-T, or the many cancer vaccines that are in full swing of development, they are just the tip of the immunological iceberg. Researchers are digging into the iceberg to find out more about how to control the immune response and how these therapies can be used in the clinic to reap the benefits, giving us more and more hope for survival, and perhaps the hope of conquering cancer. Expect more breakthroughs in immunotherapy and more miracles for cancer patients.</p>","autoDesc":true}`);export{y as comp,b as data};
